TFPI Alpha and Beta Regulate mRNAs and microRNAs Involved in Cancer Biology and in the Immune System in Breast Cancer Cells

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Stavik, Benedicte ^a,c   Skretting, Grethe ^b   Olstad, Ole Kristoffer ^a   Sletten, Marit ^a   Dehli Vigeland, Magnus ^a   Sandset, Per Morten ^b,c   Iversen, Nina ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; JANUS KINASE; MESSENGER RNA; MICRORNA; PHOSPHOPROTEIN; PROTEIN KINASE B; STAT PROTEIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR ALPHA; TISSUE FACTOR PATHWAY INHIBITOR BETA; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GENETICS; CANCER INVASION; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CELL MOTION; CLUSTER ANALYSIS; COLONY FORMATION; CONTROLLED STUDY; CYTOLOGY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; PHENOTYPE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VALIDATION STUDY; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, CELLULAR; LIPOPROTEINS; MICRORNAS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84867150346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047184     Document Type: Article

References (49)

1. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ, (1988) Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 263: 6001-6004.
2. Zhang J, Piro O, Lu L, Broze GJ, (2003) Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation 108: 623-627.
3. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, et al. (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. PNAS 100: 10393-10398.
4. Lee RC, Feinbaum RL, Ambros V, (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
5. Kwak PB, Iwasaki S, Tomari Y, (2010) The microRNA pathway and cancer. Cancer Science 101: 2309-2315.
6. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
7. Miska EA, (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568.
8. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
9. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells. J Biol Chem 283: 1026-1033.
10. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, et al. (2009) Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis. Cancer Res 69: 1279-1283.
11. Si ML, Zhu S, Wu H, Lu Z, Wu F, et al. (2007) miR-21-mediated tumor growth. Oncogene 26: 2799-2803.
12. O'Day E, Lal A, (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12: 201.
13. Le Quesne J, Caldas C, (2010) Micro-RNAs and breast cancer. Mol Oncol 4: 230-241.
14. Kurer MA, (2007) Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells. Mol Biol Rep 34: 221-224.
15. Sierko E, Wojtukiewicz MZ, Zimnoch L, Kisiel W, (2010) Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue. Thromb Haemost 103: 198-204.
16. Hembrough TA, Swartz GM, Papathanassiu A, Vlasuk GP, Rote WE, et al. (2003) Tissue Factor/Factor VIIa Inhibitors Block Angiogenesis and Tumor Growth Through a Nonhemostatic Mechanism. Cancer Res 63: 2997-3000.
17. Amirkhosravi A, Meyer T, Chang JY, Amaya M, Siddiqui F, et al. (2002) Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 87: 930-936.
18. Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N, (2010) Overexpression of both TFPIalpha and TFPIbeta induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells. Mol Carcinog 49: 951-963.
19. Dallas P, Gottardo N, Firth M, Beesley A, Hoffmann K, et al. (2005) Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? BMC Genomics 6: 59.
20. Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, et al. (2011) Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility. BMC Cancer 11: 357.
21. DeNardo D, Coussens L, (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9: 212.
22. Homey B, Muller A, Zlotnik A, (2002) Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2: 175-184.
23. Collison A, Foster PS, Mattes J, (2009) Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses. Clin Exp Pharmacol Physiol 36: 1049-1053.
24. Van Den Boogaard FE, Brands X, Schultz MJ, Levi M, Roelofs JJ, et al. (2011) Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia. J Thromb Haemost 9: 122-132.
25. Uray IP, Brown PH, (2011) Chemoprevention of hormone receptor-negative breast cancer: new approaches needed. Recent Results Cancer Res 188: 147-162.
26. Lacroix M, Leclercq G, (2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289.
27. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
28. Shirotani-Ikejima H, Kokame K, Hamuro T, Bu G, Kato H, et al. (2002) Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs. Biochem Biophys Res Commun 299: 847-852.
29. Lewis TS, Shapiro PS, Ahn NG (1998) Signal Transduction through MAP Kinase Cascades. In: George FV, editors. Advances in Cancer Research. Academic Press. 49-139.
30. Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, et al. (1994) Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54: 5280-5283.
31. Casalini P, Botta L, Ménard S, (2001) Role of p53 in HER2-induced Proliferation or Apoptosis. J Biol Chem 276: 12449-12453.
32. Danielsen AJ, Maihle NJ, (2002) The EGF/ErbB receptor family and apoptosis. Growth Factors 20: 1-15.
33. Harris RA, Hiles ID, Page MJ, O'Hare MJ, (1995) The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br J Cancer 72: 386-392.
34. Wang Z, Wang M, Carr BI, (2008) Integrin alpha5-induced EGFR activation by prothrombin triggers hepatocyte apoptosis via the JNK signaling pathway. J Cell Physiol 216: 551-557.
35. Högnason T, Chatterjee S, Vartanian T, Ratan RR, Ernewein KM, et al. (2001) Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling. FEBS Lett 491: 9-15.
36. Zhao XR, Dai WT, Zhu HF, Zhang Y, Cao LM, et al. (2006) Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane. Cell Biol Int 30: 653-658.
37. Tikhomirov O, Carpenter G, (2004) Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2. J Biol Chem 279: 12988-12996.
38. Filmus J, Pollak MN, Cailleau R, Buick RN, (1985) MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128: 898-905.
39. Provencal M, Michaud M, Beaulieu E, Ratel D, Rivard GE, et al. (2008) Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins. Thromb Haemost 99: 576-585.
40. Fassan M, Baffa R, Palazzo J, Lloyd J, Crosariol M, et al. (2009) MicroRNA expression profiling of male breast cancer. Breast Cancer Res 11: R58.
41. Shi M, Guo N, (2009) MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treat Rev 35: 328-334.
42. Shi M, Liu D, Duan H, Shen B, Guo N, (2010) Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 29: 785-799.
43. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8: R214.
44. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Res 65: 7065-7070.
45. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, et al. (2009) Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth. Cancer Res 69: 8332-8340.
46. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, et al. (2011) miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS One 6: e16915.
47. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
48. Masri S, Liu Z, Phung S, Wang E, Yuan YC, et al. (2010) The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res Treat 124: 89-99.
49. Wu Zs, Wu Q, Wang Cq, Wang Xn, Wang Y, et al. (2010) MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer 10: 542.